Linking process understanding to control strategy

International Pharmaceutical Federation (FIP) and Royal Pharmaceutical Society of Great Britain conference

Pharmaceutical manufacturing is going through a major transition phase. The industry is moving from quality by end testing to quality by design using a more holistic control strategy. However, this requires enhanced scientific understanding of the pharmaceutical processes including a scientific appreciation of the criticality of each process step.

Goal of the conference: The Quality-International Conference 2007 aims to discuss the operational definitions of criticality for the five most common pharmaceutical manufacturing processes, thereby contributing to a more harmonized understanding of process criticality across the pharmaceutical industry. The conference has already invited fifteen leading experts in the field of API, biotech, tablet and parenteral manufacturing to present their views and to give in case studies practical approaches on how to tackle process criticality. Moreover the conference gives you the possibility to present your view on the matter either in a poster or a short oral presentation.

Who should attend?
• Industrial colleagues from pharmaceutical development and manufacturing (API, biotech, dosage forms), regulatory affairs, quality control, quality assurance, etc.
• Regulatory authorities and inspectorates
• Academic colleagues

The organizing committee kindly invites you to:
1. Come with suggestions for the scientific programme
2. Indicate whether you are interested to give a podium or poster presentation
3. Mark the dates in your agenda and pre-register for the meeting

Registration required:

Yes

Free:

No